Search Results - "Carfagna, Nicola"

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor by Wong, Erik H.F., Sonders, Mark S., Amara, Susan G., Tinholt, Paula M., Piercey, Montford F.P., Hoffmann, William P., Hyslop, Deborah K., Franklin, Stanley, Porsolt, Roger D., Bonsignori, Alberto, Carfagna, Nicola, McArthur, Robert A.

“…Background: Reboxetine is a potent antidepressant, with efficacy comparable to that of imipramine, desipramine, and fluoxetine, and has improved side-effect…”
Get full text

Neuroprotective effects of nicergoline in immortalized neurons by Sortino, Maria Angela, Battaglia, Angelo, Pamparana, Franco, Carfagna, Nicola, Post, Claes, Canonico, Pier Luigi

“…We studied the potential neuroprotective action of nicergoline in immortalized hypothalamic GT1-7 cells exposed to agents which deplete levels of reduced…”
Get full text

Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats by Carfagna, Nicola, Di Clemente, Angelo, Cavanus, Stefano, Damiani, Domenico, Gerna, Marco, Salmoiraghi, Patrizia, Cattaneo, Barbara, Post, Claes

“…The effects of nicergoline on basal and K +-stimulated release of ACh in the hippocampus of 3- and 19-month old rats has been studied by microdialysis. A…”
Get full text

Antioxidant properties of MDL and MMDL, two nicergoline metabolites, during chronic administration of haloperidol by Vairetti, Mariapia, Battaglia, Angelo, Carfagna, Nicola, Luigi Canonico, Pier, Bertè, Francantonio, Richelmi, Plinio

“…We evaluated the effects of 10-alpha-methoxy-9,10-dihydrolysergol (MDL) and 1-methyl-10-alpha-methoxy-9,10-dihydrolysergol (MMDL), two nicergoline metabolites,…”
Get full text

Nicergoline in dementia: A review of its pharmacological properties and therapeutic potential by WINBLAD, Bengt, CARFAGNA, Nicola, BONURA, Luisa, ROSSINI, Bianca M, WONG, Eric H. F, BATTAGLIA, Angelo

“…Nicergoline is a semisynthetic ergoline derivative indicated for the treatment of cognitive impairment in various forms of dementia. It is currently available…”
Get full text

Modulation of phosphoinositide turnover by chronic nicergoline in rat brain by Carfagna, Nicola, Cavanus, Stefano, Damiani, Domenico, Salmoiraghi, Patrizia, Fariello, Ruggero, Post, Claes

“…Basal and agonist-stimulated phosphoinositide (PI) turnover and inositol 1,4,5 -trisphospate (InsP 3) content in rat brain were investigated after chronic…”
Get full text

Effects of Nicergoline on Age-Related Decrements in Radial Maze Performance and Acetylcholine Levels by McArthur, Robert A., Carfagna, Nicola, Banfi, Laura, Cavanus, Stefano, Cervini, Maria Antonietta, Fariello, Ruggero, Post, Claes

“…The effects of chronic oral administration of nicergoline (5.0 mg/kg; bid) on locomotor activity, eight-arm radial maze performance plus striatal, cortical,…”
Get full text

(E) and (Z)-3-Styrylpiperidines as sigma ligands by Mantegani, Sergio, Brambilla, Enzo, Cremonesi, Paolo, Caccia, Carla, Fornaretto, Maria Gioia, Carfagna, Nicola, Colombo, Monica, McArthur, Robert A., Varasi, Mario

“…A class of (E) and (Z)-3-styrylpiperidine derivatives was prepared as racemates and evaluated for affinity at σ binding sites labeled with […”
Get full text

Preparation of 7-oxaaporphine derivatives and evaluation of their dopaminergic activity by Banzatti, Carlo, Carfagna, Nicola, Commisso, Roberto, Heidempergher, Franco, Pegrassi, Lorenzo, Melloni, Piero

“…A series of 7-oxaaporphine derivatives was prepared. The compounds were evaluated as dopaminergic agents. None of them showed either affinity for dopamine…”
Get full text